Inquiry Basket
DBCO-PEG4-GGFG-DX8951 is a drug-linker conjugate for ADC by using DX8951 (Synonyms: Exatecan, a DNA topoisomerase I inhibitor), linked via DBCO-PEG4-GGFG.
| Catalog Number | Size | Price | Quantity | ||
|---|---|---|---|---|---|
| BADC-00764 | -- | $-- | Inquiry |
DBCO-PEG4-GGFG-DX8951, a cutting-edge conjugate utilized in targeted drug delivery and bioorthogonal chemistry, offers a myriad of applications. Here are four key applications:
Targeted Drug Delivery: Leveraging the unique capabilities of DBCO-PEG4-GGFG-DX8951, researchers can precisely deliver medications to specific cells or tissues, significantly boosting the effectiveness of therapies. The DBCO moiety facilitates click chemistry with azide-functionalized biomolecules, ensuring meticulous conjugation and delivery. This targeted strategy minimizes off-target effects and mitigates the systemic toxicity of chemotherapeutic agents.
Bioorthogonal Chemistry: A cornerstone of bioorthogonal chemistry, DBCO-PEG4-GGFG-DX8951 enables intricate click reactions that allow for pinpoint modifications of biomolecules within living systems without disturbing native biochemical processes. Scientists utilize this conjugate to selectively label proteins, nucleic acids, and other biomolecules, opening up avenues for studying nuanced biological systems and crafting sophisticated diagnostic tools with unparalleled specificity.
Antibody-Drug Conjugates: DBCO-PEG4-GGFG-DX8951 plays a pivotal role as a linker in the creation of antibody-drug conjugates (ADCs), a revolutionary class of targeted cancer therapies. The PEG4 spacer enhances the solubility and stability of the conjugate, while the GGFG peptide sequence provides a cleavable site for controlled drug release within the target milieu. This innovative approach results in superior treatment outcomes with diminished side effects, offering renewed hope in the fight against cancer.
Theranostics: In the realm of theranostics, DBCO-PEG4-GGFG-DX8951 shines, offering combined therapeutic and diagnostic functionalities for tailored treatment regimens. By coupling this compound with imaging agents, clinicians can monitor drug delivery and therapeutic efficacy in real-time, enabling personalized treatment strategies and enhancing patient outcomes across various diseases, notably cancer. This dual-purpose feature underscores the transformative potential of DBCO-PEG4-GGFG-DX8951 in advancing precision medicine practices.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
